PTGX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2025-11-06 compared with 2025-08-06 · 3 added, 3 removed, 29 unchanged (17% of the section changed)
1 unchanged sentence
(c) Trading Plans
−Removed: During the fiscal quarter ended June 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K).
+Added: During the fiscal quarter ended September 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K).
EXHIBIT INDEX
20 unchanged sentences
PROTAGONIST THERAPEUTICS, INC.
−Removed: August 6, 2025
+Added: November 6, 2025
/s/ Dinesh V.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 6, 2025
+Added: November 6, 2025
Executive Vice President, Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.